Royalty Report: Drugs, Diagnostic, Vaccine – Collection: 263930

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Diagnostic
  • Vaccine
  • Cancer
  • Disease
  • Delivery

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 263930

License Grant
The University grants a license under the patent rights to develop, make, have made, use, sell, offer to sell, lease, and import Licensed products in the Field in the Territory and to develop and perform Licensed processes in the Field in the Territory.
License Property
The licensed patents are titled
–Method for Screening Libraries of Enzymes with Improved Catalytic Properties or Altered Substrate Specificity Using Microwells for the Spatial Separation of Cells Producing the Enzymes;
–Method for Diagnosing Allergic Reactions;
–Method for Detecting Active and Latent Virally Infected Cells;
–Method for Assessing Cytotoxicity of Single Cells;
–Composition of an Array of Microwells with an Integrated Microfluidic System; and,
–Screening Assays and Methods.

The Apparatus Product shall mean a Licensed Product that is a microarray comprising microwells.

The Diagnostic Product shall mean a Licensed Product or Discovered Product that is used or intended for use  in the diagnosis and/or prognosis of diseases or conditions, and/or for the medical management of disease or conditions, including without limitation the determination of a particular intervention for the prevention and/or treatment of disease, in humans, including without limitation application specific reagents and kits.

The Therapeutic Product shall mean a Licensed Product or Discovered Product that is used or intended for use in the treatment and/or prevention of human disease, including, without limitation, therapeutic and prophylactic vaccines.

The Veterinary product shall mean a Licensed product or Discovered product that is used or intended for use in the diagnosis and/or prognosis of disease in non-human animals, and/or the determination of a particular intervention for the prevention and/or treatment of disease, including without limitation application specific reagents and kits, and/or the treatment and/or prevention of disease in non-human animals, including without limitation therapeutic and prophylactic vaccines.

Field of Use
The Field of use shall mean all fields.

IPSCIO Record ID: 256328

License Grant
This amendment revises the listed patents.  Per the restated agreement, Licensor grants and agrees to grant to Licensee, upon the terms and conditions set forth in this Agreement, the exclusive rights under the Licensed Intellectual Property to make, have made, use and sell Licensed Products and Licensed Processes throughout the world and otherwise to exploit the Licensed Intellectual Property commercially throughout the world.
License Property
With this amendment, the patents are expanded and include Whole Recombinant Yeast Vaccine Activates Dendritic Cells and Elicits Protective Cell-Mediated Immunity, and, Yeast Dendritic Cell Vaccines and Uses Thereof, and, Yeast-Antigen Compositions And Methods Of Making The Same.
Field of Use
Per the restated agreement, the field of use is research and investigation for cancer therapies.

IPSCIO Record ID: 328128

License Grant
The University grants an exclusive license to their rights in the patent rights to develop, make, have made, use, sell, offer to sell, lease, and import Licensed Products in the Field in the Territory and to develop and perform Licensed Processes solely to the extent necessary to develop Licensed Products and Identified Products in the Field in the Territory.
License Property
The Licensors are owners of patent rights for Alternatively Spliced mRNA Isoforms as Prognostic and Therapeutic Tools for Metastatic Breast Cancer and Other Invasive/Metastatic Cancers, and,  Alternatively Spliced mRNA Isoforms As Prognostic Indicators For Metastatic Cancer.
Field of Use
Patents and technology surround the discoveries of alternatively spliced mRNA and protein isoform markers for the diagnosis and prognosis of cancer through the epithelial to mesenchymal transition (“EMT”) in epithelial solid tumor cancers.

Field shall mean use or intended for use in the diagnosis and/or prognosis of cancer, and/or for the medical management of cancer, including without limitation the determination (whether by selection or exclusion) of a particular intervention for the prevention and/or treatment of cancer, in humans, including without limitation the use of specific reagents, kits or diagnostic devices.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.